Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Germany(2,166/week)
    • France(1,295/week)
    • Poland(1,222/week)
    • Spain(887/week)
    • Italy(461/week)
    • View all (9,891/week)
  • News
    • United States(396/week)
    • Manufacturing(281/week)
    • Energy(237/week)
    • Technology(312/week)
    • Other Manufacturing(239/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Chiesi

Feb 23, 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease
Feb 10, 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Present Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 17th Annual WORLDSymposium(TM) 2021
Dec 30, 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Nov 27, 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Aug 24, 2020
Protalix BioTherapeutics Announces Completion of the Treatment Period for its Phase III BRIGHT Clinical Trial of Pegunigalsidase Alfa (PRX-102) for the Proposed Treatment of Fabry Disease

Latest News

Mar 31, 2023

Knightscope to Present at the Emerging Growth Conference

Mar 31, 2023

Airgas Welcomes 55 Schools into High School Welding Education Initiative Class of 2023

Mar 31, 2023

PBPC Annual Conference Convenes Industry Leaders, Innovators, & Lawmakers on Bioeconomy Landscape, Policy...

Mar 31, 2023

Microvast Announces Location of First Polyaramid Separator Plant in Kentucky

Mar 31, 2023

Ascent Industries Sets Fourth Quarter and Full Year 2022 Earnings Conference Call for March 31, 2023, at 8:30...

Mar 31, 2023

Port Houston Expands Resin Packaging Footprint

Mar 31, 2023

H.I.G. Capital Acquires Synecore Limited and Meesons Futures Limited to Create the Andwis Group

Mar 31, 2023

Sex Therapist Deb Laino Offers Tips in Response to Increased STD Rates Among Older Adults

View all News

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2023 EPICOS
Made by Wedia